[SaneVax: According to the FDA mission statement, “FDA is (also) responsible for advancing the public health by helping to speed innovations that make medicines more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medicines and foods to maintain and improve their health.” Read the following article and judge for yourself whether their mission statement has any basis in reality.]
Exposing the FDA’s Vaccine Injury Cover-up: An Interview With Walter Kyle, Esq.
By Catherine J. Frompovich
Attorney Walter Kyle of Cape Cod, Massachusetts, began representing Plaintiffs with vaccine injuries ten years before the Vaccine Injury Act began, and has argued more than forty cases before the Special Masters of the United States Court of Federal Claims [under the Vaccine Injury Compensation Act] – 42 U.S.C.A. §300aa, et.seq. As a result, Attorney Kyle has unique insight into the nuances of vaccine injury law.
To start our interview, may I ask how you became involved in vaccine law?
I began representation of vaccine-injured clients in Arkansas in 1977. My first case out of law school was representing a paraplegic mother who acquired paralytic polio from mutated Sabin live trivalent oral polio vaccine [TOPV] viruses shed from her three-month-old infant’s diapers. Centers for Disease control classified the woman in the “immune deficient” category of “vaccine associated contact cases” from Type 2 Sabin vaccine.
Walter, you just mentioned the phrase “vaccine viruses shed.” For those who are not familiar with such terminology I’d like to say it means certain types of vaccines contain certain viruses that are alive and once injected into [orally administered to] an individual can infect others via contact with bodily fluids, excrement, and sometimes coughing or sneezing. In your first vaccine case, the mother contracted paralytic polio from viruses “shed” in her infant’s diapers soiled with urine and feces.
Walter, how did you present that case at court?
In the first case against the manufacturer, American Cyanamid, which defended based on the fact that the woman was categorized as “immune deficient” and implied the reaction was her fault, I countered with the position that the Type 2 vaccine caused her immune deficiency since she had never been sick in her life before contact with that vaccine. After settling that lawsuit against the manufacturer for failure to warn, I instituted a Federal Tort Claims Act (FTCA) lawsuit against HEW for regulatory violations in the license and release of OPV, in general, and the individual Lot of polio vaccine, in particular. In addition, I challenged the FDA’s intention to use Sabin’s live oral polio vaccine (OPV) for immunization of unwitting contacts of vaccine recipients as an unconstitutional invasion of their privacy (see Loge v. United States, 662 F.2d 1268 8th Cir. 1981), which evolved into civil actions of “battery” against the sole manufacturer of the Sabin vaccine –American Cyanamid.